| Dr David Eric Newcomb Ii, MD | |
|
Emergency Department Mid-michigan Regional Med Ctr, 4005 Orchard Drive, Midland, MI 48670-0001 | |
| (989) 839-3230 | |
| Not Available |
| Full Name | Dr David Eric Newcomb Ii |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 21 Years |
| Location | Emergency Department Mid-michigan Regional Med Ctr, Midland, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326158072 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 4301081667 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Midmichigan Medical Center-midland | Midland, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mymichigan Medical Center Gladwin | 0143262915 | 57 |
| Mymichigan Medical Center Midland | 2264323633 | 338 |
News Archive
Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness, according to new research from The University of Texas MD Anderson Cancer Center. Understanding cost differences should help guide informed discussions between patients and physicians when considering chemotherapy options.
Hypatia Research, LLC today released a report entitled "What Healthcare CIOs Need to Know About ARRA & EHR: Healthcare Technology Solutions & Service Providers" outlining current developments, major adoption challenges, business case justification and an assessment of more than 30 EHR vendors that meet government standards for certification and funding programs.
UPMC for You, the Medical Assistance program of UPMC Health Plan, was honored by the Medicaid Health Plans of America Institute for Medicaid Innovation for demonstrating innovative and effective approaches to providing services that have improved the health of Medicaid enrollees, at MHPA's annual Best Practices Awards program held in Washington, D.C., earlier this month.
The Food and Drug Administration (FDA) has approved Zyrtec-D (cetirizine HCl 5 mg and pseudoephedrine HCl 120 mg), an allergy drug, for nonprescription use in adults and children 12 years of age and older. This drug combines an antihistamine with a nasal decongestant.
Disputes between healthcare professionals and patients and/or their families about whether medical treatment is futile can be resolved through collaborative efforts and communication, say experts.
› Verified 9 days ago
| Entity Name | Mymichigan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740230127 PECOS PAC ID: 4981501939 Enrollment ID: O20040126000905 |
News Archive
Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness, according to new research from The University of Texas MD Anderson Cancer Center. Understanding cost differences should help guide informed discussions between patients and physicians when considering chemotherapy options.
Hypatia Research, LLC today released a report entitled "What Healthcare CIOs Need to Know About ARRA & EHR: Healthcare Technology Solutions & Service Providers" outlining current developments, major adoption challenges, business case justification and an assessment of more than 30 EHR vendors that meet government standards for certification and funding programs.
UPMC for You, the Medical Assistance program of UPMC Health Plan, was honored by the Medicaid Health Plans of America Institute for Medicaid Innovation for demonstrating innovative and effective approaches to providing services that have improved the health of Medicaid enrollees, at MHPA's annual Best Practices Awards program held in Washington, D.C., earlier this month.
The Food and Drug Administration (FDA) has approved Zyrtec-D (cetirizine HCl 5 mg and pseudoephedrine HCl 120 mg), an allergy drug, for nonprescription use in adults and children 12 years of age and older. This drug combines an antihistamine with a nasal decongestant.
Disputes between healthcare professionals and patients and/or their families about whether medical treatment is futile can be resolved through collaborative efforts and communication, say experts.
› Verified 9 days ago
| Entity Name | Mymichigan Medical Center Alma |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265596126 PECOS PAC ID: 3375451404 Enrollment ID: O20040202000975 |
News Archive
Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness, according to new research from The University of Texas MD Anderson Cancer Center. Understanding cost differences should help guide informed discussions between patients and physicians when considering chemotherapy options.
Hypatia Research, LLC today released a report entitled "What Healthcare CIOs Need to Know About ARRA & EHR: Healthcare Technology Solutions & Service Providers" outlining current developments, major adoption challenges, business case justification and an assessment of more than 30 EHR vendors that meet government standards for certification and funding programs.
UPMC for You, the Medical Assistance program of UPMC Health Plan, was honored by the Medicaid Health Plans of America Institute for Medicaid Innovation for demonstrating innovative and effective approaches to providing services that have improved the health of Medicaid enrollees, at MHPA's annual Best Practices Awards program held in Washington, D.C., earlier this month.
The Food and Drug Administration (FDA) has approved Zyrtec-D (cetirizine HCl 5 mg and pseudoephedrine HCl 120 mg), an allergy drug, for nonprescription use in adults and children 12 years of age and older. This drug combines an antihistamine with a nasal decongestant.
Disputes between healthcare professionals and patients and/or their families about whether medical treatment is futile can be resolved through collaborative efforts and communication, say experts.
› Verified 9 days ago
| Entity Name | Mymichigan Medical Center Midland |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205889490 PECOS PAC ID: 2264323633 Enrollment ID: O20040324000137 |
News Archive
Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness, according to new research from The University of Texas MD Anderson Cancer Center. Understanding cost differences should help guide informed discussions between patients and physicians when considering chemotherapy options.
Hypatia Research, LLC today released a report entitled "What Healthcare CIOs Need to Know About ARRA & EHR: Healthcare Technology Solutions & Service Providers" outlining current developments, major adoption challenges, business case justification and an assessment of more than 30 EHR vendors that meet government standards for certification and funding programs.
UPMC for You, the Medical Assistance program of UPMC Health Plan, was honored by the Medicaid Health Plans of America Institute for Medicaid Innovation for demonstrating innovative and effective approaches to providing services that have improved the health of Medicaid enrollees, at MHPA's annual Best Practices Awards program held in Washington, D.C., earlier this month.
The Food and Drug Administration (FDA) has approved Zyrtec-D (cetirizine HCl 5 mg and pseudoephedrine HCl 120 mg), an allergy drug, for nonprescription use in adults and children 12 years of age and older. This drug combines an antihistamine with a nasal decongestant.
Disputes between healthcare professionals and patients and/or their families about whether medical treatment is futile can be resolved through collaborative efforts and communication, say experts.
› Verified 9 days ago
| Entity Name | Mymichigan Medical Center Alpena |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508332792 PECOS PAC ID: 8527969922 Enrollment ID: O20040415000495 |
News Archive
Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness, according to new research from The University of Texas MD Anderson Cancer Center. Understanding cost differences should help guide informed discussions between patients and physicians when considering chemotherapy options.
Hypatia Research, LLC today released a report entitled "What Healthcare CIOs Need to Know About ARRA & EHR: Healthcare Technology Solutions & Service Providers" outlining current developments, major adoption challenges, business case justification and an assessment of more than 30 EHR vendors that meet government standards for certification and funding programs.
UPMC for You, the Medical Assistance program of UPMC Health Plan, was honored by the Medicaid Health Plans of America Institute for Medicaid Innovation for demonstrating innovative and effective approaches to providing services that have improved the health of Medicaid enrollees, at MHPA's annual Best Practices Awards program held in Washington, D.C., earlier this month.
The Food and Drug Administration (FDA) has approved Zyrtec-D (cetirizine HCl 5 mg and pseudoephedrine HCl 120 mg), an allergy drug, for nonprescription use in adults and children 12 years of age and older. This drug combines an antihistamine with a nasal decongestant.
Disputes between healthcare professionals and patients and/or their families about whether medical treatment is futile can be resolved through collaborative efforts and communication, say experts.
› Verified 9 days ago
| Entity Name | Mymichigan Medical Center Clare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225081862 PECOS PAC ID: 7012829773 Enrollment ID: O20040720000582 |
News Archive
Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness, according to new research from The University of Texas MD Anderson Cancer Center. Understanding cost differences should help guide informed discussions between patients and physicians when considering chemotherapy options.
Hypatia Research, LLC today released a report entitled "What Healthcare CIOs Need to Know About ARRA & EHR: Healthcare Technology Solutions & Service Providers" outlining current developments, major adoption challenges, business case justification and an assessment of more than 30 EHR vendors that meet government standards for certification and funding programs.
UPMC for You, the Medical Assistance program of UPMC Health Plan, was honored by the Medicaid Health Plans of America Institute for Medicaid Innovation for demonstrating innovative and effective approaches to providing services that have improved the health of Medicaid enrollees, at MHPA's annual Best Practices Awards program held in Washington, D.C., earlier this month.
The Food and Drug Administration (FDA) has approved Zyrtec-D (cetirizine HCl 5 mg and pseudoephedrine HCl 120 mg), an allergy drug, for nonprescription use in adults and children 12 years of age and older. This drug combines an antihistamine with a nasal decongestant.
Disputes between healthcare professionals and patients and/or their families about whether medical treatment is futile can be resolved through collaborative efforts and communication, say experts.
› Verified 9 days ago
| Entity Name | Harbor Beach Community Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619059458 PECOS PAC ID: 7214903483 Enrollment ID: O20040908001458 |
News Archive
Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness, according to new research from The University of Texas MD Anderson Cancer Center. Understanding cost differences should help guide informed discussions between patients and physicians when considering chemotherapy options.
Hypatia Research, LLC today released a report entitled "What Healthcare CIOs Need to Know About ARRA & EHR: Healthcare Technology Solutions & Service Providers" outlining current developments, major adoption challenges, business case justification and an assessment of more than 30 EHR vendors that meet government standards for certification and funding programs.
UPMC for You, the Medical Assistance program of UPMC Health Plan, was honored by the Medicaid Health Plans of America Institute for Medicaid Innovation for demonstrating innovative and effective approaches to providing services that have improved the health of Medicaid enrollees, at MHPA's annual Best Practices Awards program held in Washington, D.C., earlier this month.
The Food and Drug Administration (FDA) has approved Zyrtec-D (cetirizine HCl 5 mg and pseudoephedrine HCl 120 mg), an allergy drug, for nonprescription use in adults and children 12 years of age and older. This drug combines an antihistamine with a nasal decongestant.
Disputes between healthcare professionals and patients and/or their families about whether medical treatment is futile can be resolved through collaborative efforts and communication, say experts.
› Verified 9 days ago
| Entity Name | Mymichigan Medical Center Gladwin |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881869774 PECOS PAC ID: 0143262915 Enrollment ID: O20081024000094 |
News Archive
Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness, according to new research from The University of Texas MD Anderson Cancer Center. Understanding cost differences should help guide informed discussions between patients and physicians when considering chemotherapy options.
Hypatia Research, LLC today released a report entitled "What Healthcare CIOs Need to Know About ARRA & EHR: Healthcare Technology Solutions & Service Providers" outlining current developments, major adoption challenges, business case justification and an assessment of more than 30 EHR vendors that meet government standards for certification and funding programs.
UPMC for You, the Medical Assistance program of UPMC Health Plan, was honored by the Medicaid Health Plans of America Institute for Medicaid Innovation for demonstrating innovative and effective approaches to providing services that have improved the health of Medicaid enrollees, at MHPA's annual Best Practices Awards program held in Washington, D.C., earlier this month.
The Food and Drug Administration (FDA) has approved Zyrtec-D (cetirizine HCl 5 mg and pseudoephedrine HCl 120 mg), an allergy drug, for nonprescription use in adults and children 12 years of age and older. This drug combines an antihistamine with a nasal decongestant.
Disputes between healthcare professionals and patients and/or their families about whether medical treatment is futile can be resolved through collaborative efforts and communication, say experts.
› Verified 9 days ago
| Entity Name | Mymichigan Medical Center West Branch |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538566765 PECOS PAC ID: 7214251081 Enrollment ID: O20160714002424 |
News Archive
Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness, according to new research from The University of Texas MD Anderson Cancer Center. Understanding cost differences should help guide informed discussions between patients and physicians when considering chemotherapy options.
Hypatia Research, LLC today released a report entitled "What Healthcare CIOs Need to Know About ARRA & EHR: Healthcare Technology Solutions & Service Providers" outlining current developments, major adoption challenges, business case justification and an assessment of more than 30 EHR vendors that meet government standards for certification and funding programs.
UPMC for You, the Medical Assistance program of UPMC Health Plan, was honored by the Medicaid Health Plans of America Institute for Medicaid Innovation for demonstrating innovative and effective approaches to providing services that have improved the health of Medicaid enrollees, at MHPA's annual Best Practices Awards program held in Washington, D.C., earlier this month.
The Food and Drug Administration (FDA) has approved Zyrtec-D (cetirizine HCl 5 mg and pseudoephedrine HCl 120 mg), an allergy drug, for nonprescription use in adults and children 12 years of age and older. This drug combines an antihistamine with a nasal decongestant.
Disputes between healthcare professionals and patients and/or their families about whether medical treatment is futile can be resolved through collaborative efforts and communication, say experts.
› Verified 9 days ago
| Entity Name | Sound Physicians Emergency Medicine Of Michigan, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568913473 PECOS PAC ID: 6800178195 Enrollment ID: O20170120002764 |
News Archive
Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness, according to new research from The University of Texas MD Anderson Cancer Center. Understanding cost differences should help guide informed discussions between patients and physicians when considering chemotherapy options.
Hypatia Research, LLC today released a report entitled "What Healthcare CIOs Need to Know About ARRA & EHR: Healthcare Technology Solutions & Service Providers" outlining current developments, major adoption challenges, business case justification and an assessment of more than 30 EHR vendors that meet government standards for certification and funding programs.
UPMC for You, the Medical Assistance program of UPMC Health Plan, was honored by the Medicaid Health Plans of America Institute for Medicaid Innovation for demonstrating innovative and effective approaches to providing services that have improved the health of Medicaid enrollees, at MHPA's annual Best Practices Awards program held in Washington, D.C., earlier this month.
The Food and Drug Administration (FDA) has approved Zyrtec-D (cetirizine HCl 5 mg and pseudoephedrine HCl 120 mg), an allergy drug, for nonprescription use in adults and children 12 years of age and older. This drug combines an antihistamine with a nasal decongestant.
Disputes between healthcare professionals and patients and/or their families about whether medical treatment is futile can be resolved through collaborative efforts and communication, say experts.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Eric Newcomb Ii, MD 117 Longman Ln, Ann Arbor, MI 48103-4028 Ph: (734) 846-1630 | Dr David Eric Newcomb Ii, MD Emergency Department Mid-michigan Regional Med Ctr, 4005 Orchard Drive, Midland, MI 48670-0001 Ph: (989) 839-3230 |
News Archive
Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness, according to new research from The University of Texas MD Anderson Cancer Center. Understanding cost differences should help guide informed discussions between patients and physicians when considering chemotherapy options.
Hypatia Research, LLC today released a report entitled "What Healthcare CIOs Need to Know About ARRA & EHR: Healthcare Technology Solutions & Service Providers" outlining current developments, major adoption challenges, business case justification and an assessment of more than 30 EHR vendors that meet government standards for certification and funding programs.
UPMC for You, the Medical Assistance program of UPMC Health Plan, was honored by the Medicaid Health Plans of America Institute for Medicaid Innovation for demonstrating innovative and effective approaches to providing services that have improved the health of Medicaid enrollees, at MHPA's annual Best Practices Awards program held in Washington, D.C., earlier this month.
The Food and Drug Administration (FDA) has approved Zyrtec-D (cetirizine HCl 5 mg and pseudoephedrine HCl 120 mg), an allergy drug, for nonprescription use in adults and children 12 years of age and older. This drug combines an antihistamine with a nasal decongestant.
Disputes between healthcare professionals and patients and/or their families about whether medical treatment is futile can be resolved through collaborative efforts and communication, say experts.
› Verified 9 days ago
Carleton D Winegar, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4005 Orchard Dr, Midland, MI 48670 Phone: 989-839-3100 Fax: 989-839-1393 | |
Dr. Belinda Hoover Brewster, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2677 E Blackhurst Rd, Midland, MI 48642 Phone: 989-837-6632 Fax: 989-837-6632 | |
Dr. Zachary J Sawaya, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4000 Wellness Dr, Midland, MI 48670 Phone: 989-839-3000 Fax: 989-839-1393 | |
Erich Christian Kickland, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4005 Orchard Dr, Midland, MI 48670 Phone: 989-839-3100 | |
Jesse G Walker, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4005 Orchard Dr, Midland, MI 48670 Phone: 989-839-3100 Fax: 989-839-1393 | |
Jeffrey S Newman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4005 Orchard Dr, Midland, MI 48670 Phone: 989-839-3100 Fax: 989-839-1393 |